Convalescent plasma therapy for COVID-19 prophylaxis in adults early post-hematopoietic stem cell transplantation: one-year outcomes from a randomized controlled trial.
Saved in:
| Title: | Convalescent plasma therapy for COVID-19 prophylaxis in adults early post-hematopoietic stem cell transplantation: one-year outcomes from a randomized controlled trial. |
|---|---|
| Authors: | Cao Y; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China., Li Q; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China., Guo W; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China., Xu M; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China., Fang K; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China., Wang F; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China., Zhang R; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China., Li L; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China., Wei J; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China., Liu Z; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China., Liang C; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China., Zhai W; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China., Ma Q; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China., Chen X; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China., Cao W; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China., Yang D; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China., He Y; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China., Pang A; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China., Feng S; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China., Han M; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China., Sun J; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China., Jiang E; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China. |
| Source: | Frontiers in immunology [Front Immunol] 2025 Nov 28; Vol. 16, pp. 1626775. Date of Electronic Publication: 2025 Nov 28 (Print Publication: 2025). |
| Publication Type: | Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41394817 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Convalescent plasma therapy for COVID-19 prophylaxis in adults early post-hematopoietic stem cell transplantation: one-year outcomes from a randomized controlled trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Cao+Y%22">Cao Y</searchLink>; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China.<br /><searchLink fieldCode="AU" term="%22Li+Q%22">Li Q</searchLink>; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China.<br /><searchLink fieldCode="AU" term="%22Guo+W%22">Guo W</searchLink>; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China.<br /><searchLink fieldCode="AU" term="%22Xu+M%22">Xu M</searchLink>; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China.<br /><searchLink fieldCode="AU" term="%22Fang+K%22">Fang K</searchLink>; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China.<br /><searchLink fieldCode="AU" term="%22Wang+F%22">Wang F</searchLink>; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China.<br /><searchLink fieldCode="AU" term="%22Zhang+R%22">Zhang R</searchLink>; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China.<br /><searchLink fieldCode="AU" term="%22Li+L%22">Li L</searchLink>; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China.<br /><searchLink fieldCode="AU" term="%22Wei+J%22">Wei J</searchLink>; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China.<br /><searchLink fieldCode="AU" term="%22Liu+Z%22">Liu Z</searchLink>; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China.<br /><searchLink fieldCode="AU" term="%22Liang+C%22">Liang C</searchLink>; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China.<br /><searchLink fieldCode="AU" term="%22Zhai+W%22">Zhai W</searchLink>; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China.<br /><searchLink fieldCode="AU" term="%22Ma+Q%22">Ma Q</searchLink>; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China.<br /><searchLink fieldCode="AU" term="%22Chen+X%22">Chen X</searchLink>; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China.<br /><searchLink fieldCode="AU" term="%22Cao+W%22">Cao W</searchLink>; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China.<br /><searchLink fieldCode="AU" term="%22Yang+D%22">Yang D</searchLink>; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China.<br /><searchLink fieldCode="AU" term="%22He+Y%22">He Y</searchLink>; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China.<br /><searchLink fieldCode="AU" term="%22Pang+A%22">Pang A</searchLink>; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China.<br /><searchLink fieldCode="AU" term="%22Feng+S%22">Feng S</searchLink>; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China.<br /><searchLink fieldCode="AU" term="%22Han+M%22">Han M</searchLink>; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China.<br /><searchLink fieldCode="AU" term="%22Sun+J%22">Sun J</searchLink>; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China.<br /><searchLink fieldCode="AU" term="%22Jiang+E%22">Jiang E</searchLink>; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2025 Nov 28; Vol. 16, pp. 1626775. <i>Date of Electronic Publication: </i>2025 Nov 28 (<i>Print Publication: </i>2025). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Randomized Controlled Trial – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41394817 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fimmu.2025.1626775 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1626775 Titles: – TitleFull: Convalescent plasma therapy for COVID-19 prophylaxis in adults early post-hematopoietic stem cell transplantation: one-year outcomes from a randomized controlled trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Cao Y – PersonEntity: Name: NameFull: Li Q – PersonEntity: Name: NameFull: Guo W – PersonEntity: Name: NameFull: Xu M – PersonEntity: Name: NameFull: Fang K – PersonEntity: Name: NameFull: Wang F – PersonEntity: Name: NameFull: Zhang R – PersonEntity: Name: NameFull: Li L – PersonEntity: Name: NameFull: Wei J – PersonEntity: Name: NameFull: Liu Z – PersonEntity: Name: NameFull: Liang C – PersonEntity: Name: NameFull: Zhai W – PersonEntity: Name: NameFull: Ma Q – PersonEntity: Name: NameFull: Chen X – PersonEntity: Name: NameFull: Cao W – PersonEntity: Name: NameFull: Yang D – PersonEntity: Name: NameFull: He Y – PersonEntity: Name: NameFull: Pang A – PersonEntity: Name: NameFull: Feng S – PersonEntity: Name: NameFull: Han M – PersonEntity: Name: NameFull: Sun J – PersonEntity: Name: NameFull: Jiang E IsPartOfRelationships: – BibEntity: Dates: – D: 28 M: 11 Text: 2025 Nov 28 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1664-3224 Numbering: – Type: volume Value: 16 Titles: – TitleFull: Frontiers in immunology Type: main |
| ResultId | 1 |